Methodology: IHC

Clinical Significance:
Nuclear localization of SF-1 can be used to distinguish sex cord-stromal tumors (SCST) from non-sex cord-stromal tumors (e.g., borderline tumors, serous carcinomas, etc.) and is therefore useful in the differential diagnosis of these neoplasms. Antibodies to SF-1 should be run in a panel with other sex cord-stromal tumor markers, such as inhibin and calretinin. Subcellular localization: Nuclear

Organ: OB/GYN

Disease State:

CPT Code(s): 88342 or 88341. The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

Turnaround Time: Within 1-2 business days of receipt

Schedule: Monday - Friday

Specimen Requirements:
• Formalin-fixed, paraffin-embedded (FFPE) tissue block or cell block - OR - • 1 unstained slide for each test requested plus 3-4 additional unstained slides cut at 4µm